Prostatic Disease: Clinical Trials

1 trial for Prostatic Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Prostatic Disease: new trials by email Literature Review of Prostatic Disease trials Research Report on Prostatic Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC
177Lu-PSMA-617, Ipilimumab, Nivolumab - Prostatic Neoplasms, Genital Neoplasms, Male
Phase 2UnknownAustralian and New Zealand Urogenital and Prostate Cancer Trials Group932022-04-292023-12-15

Narrower conditions

Genital Neoplasms, Male (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Prostatic Diseases (1)  ·  Prostatic Neoplasms (1)  ·  Urogenital Neoplasms (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Male Urogenital Diseases (1)  ·  Urogenital Diseases (1)

Interventions

Ipilimumab (1)  ·  Nivolumab (1)  ·  Pluvicto (1)

Sponsors

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (1)

Countries

Australia (1)

Top investigators

Shahneen Sandhu, MBBS, FRACP (1)